David Roman

Stock Analyst at Goldman Sachs

(1.02)
# 2264
Out of 5,441 analysts
44
Total ratings
Success rate
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
OMDA Omada Health
Initiates Coverage On: Buy
29
19.03 52.39% 1 Jul 1, 2025
HQY HealthEquity
Maintains: Neutral
94 104
92.49 12.44% 3 Jun 4, 2025
BBNX Beta Bionics
Initiates Coverage On: Neutral
16
14.29 11.97% 1 May 30, 2025
PODD Insulet
Initiates Coverage On: Buy
380
304.75 24.69% 1 May 30, 2025
DOCS Doximity
Maintains: Neutral
80 50
61.88 -19.2% 3 May 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
120 104
100.02 3.98% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 10
6.78 47.49% 4 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
94 82
73.02 12.3% 3 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
24 23
14.66 56.89% 2 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
138 154
131.33 17.26% 2 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
42 24
10.11 137.39% 2 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
63 71
71.88 -1.22% 4 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
64 55
49.57 10.95% 2 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
42
23.47 78.95% 3 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
91 124
160.54 -22.76% 2 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
384 427
376.68 13.36% 2 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
81 90
78.21 15.07% 3 Dec 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
90
102.78 -12.43% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
500
471.96 5.94% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
274
192.59 42.27% 1 May 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
83
92.75 -10.51% 1 May 30, 2024